timothy sykes logo

Short Selling- Tim's Trading Challenge

How To Profit From The SEC Halting A Stock

Timothy SykesAvatar
Written by Timothy Sykes
Updated 1/24/2023 4 min read
How To Profit From The SEC Halting A Stock Thumbnail

I took a lot of heat all over the internet from penny stock promoters and their errand boys, TIMalert subscribers didn’t understand why I focused sooooo much time on this one company, but today, EVERYONE now understands that when you have a true GIMME, you try to make as much $ as you can off it because you know these don’t come around every day…especially when your research leads you to believe that the stock you’re shorting has done soooo much bad stuff that it’s likely they’ll get halted by the SEC.

Yes, it’s true, after a series of blatant SEC violations, Genova Biotherapeutics Inc. (GVBP) has finally been halted by the SEC. You can read the official SEC press release below, or click on the nearly one dozen blog posts I wrote cataloguing all the nasty stuff that GVBP did to earn this distinctive honor….little different than the companies I teach you about in my PennyStocking DVDs

I am short 3,000 shares at 27 cents/share, so I’ll basically make another $750 or so (most likely at .01 to .02 cents/share if and when the stock reopens) after making $2,000+ overall on this company and more than a dozen TIMalert subscribers are also still short, one subscriber has 53,000 shares (although I’m gonna ask him for a screenshot to verify!) after we’ve already made $40,000ish short selling this scum (no, I don’t regret taking most of my profits, the SEC was quick this time, usually they take weeks or months before halting, and there’s always risk of a second pump)

In the next few days, I’ll be unveiling a premium penny stock research service in which I’ll cover stocks EXACTLY like this…no more freebies and as you can see from GVBP falling from $1+ to its current 18 cent/share today before the halt, my research is not only good, it can lead to significant profits. CONTACT ME if you’re interested in being one of the first subscribers to that service. It’s gonna be limited so hurry up.

See below the SEC halt press release and my nearly one dozen article documenting all the GVBP thievery, it’s disgustingly beautiful:

SEC SUSPENDS TRADING IN THE SECURITIES OF GENOVA
BIOTHERAPEUTICS INC.

The Securities and Exchange Commission (“Commission”) announced the temporary
suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the
“Exchange Act”), of trading in the securities of Genova Biotherapeutics Inc. (“Genova”),
of New York, New York, at 9:30 a.m. on September 23, 2009, and terminating at 11:59
p.m. on October 6, 2009.

The Commission temporarily suspended trading in the securities of Genova because
questions have arisen about the stock promotional activity for Genova, and the accuracy
and adequacy of publicly available information concerning, among other things, the
company’s business operations.

Good halt, plenty of reason, now learn more from these MUST READS and you can see thier chart is EXACTLY like the pump & dumps about which I teach in these 3 videos:

More Breaking News

-GVBP’s hilarious story of travel turned cancer cure company with $35,000 in the bank

-GVBP using the old patents

-GVBP’s “partner” denying partnership 100%

-GVBP using recycled press releases

GVBP has the same address as a penny stock spammer

-GVBP issuing embarrassing Friday night press release

-GVBP’s largest shareholder selling millions of shares

-GVBP’s partners have the same address!

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”